DENVER, CO—With several P2Y12 inhibitors available, clinicians are increasingly faced with choices about whether to switch their patients with ACS or a recent stent implantation from one to another, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback